[Form 4] Resideo Technologies, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Resideo Technologies insider filing: Michael Carlet, the company's Chief Financial Officer, reported a purchase of 1,540 shares of Resideo Technologies, Inc. (REZI) on 08/09/2025 at a reported price of $27.37 per share. Following the transaction his beneficial ownership is reported as 160,861 shares. The transaction is recorded on a Form 4 and is shown with transaction code F.

Insights

Financial Analyst

TL;DR: CFO purchase of 1,540 REZI shares reported; modest size relative to his total holding, appears routine.

The filing documents an insider purchase that increases Michael Carlet's beneficial ownership to 160,861 shares. The acquisition of 1,540 shares at $27.37 raises his holding by 1,540 shares, which is roughly 0.96% of his post-transaction holdings. No derivative transactions are reported in this filing. Based solely on the disclosed numbers, the trade appears small in absolute terms and does not, by itself, indicate a material change to ownership structure.

Corporate Governance Expert

TL;DR: Form 4 filed by one reporting person; signature executed by an attorney-in-fact; disclosure appears complete for the reported transaction.

The Form 4 shows the report was filed for a single reporting person and is signed by an attorney-in-fact. The record includes transaction code 'F' and shows no derivative securities reported. From a disclosure-compliance perspective, the required elements (reporting person, issuer, transaction date, number of shares, price, and resulting beneficial ownership) are present in the filing text provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carlet Michael

(Last) (First) (Middle)

16100 N 71ST STREET

SUITE 550

(Street)

SCOTTSDALE AZ 85254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RESIDEO TECHNOLOGIES, INC. [ REZI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/09/2025		F		1,540	D	$27.37	160,861	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jeannine J. Lane, as Attorney-in-Fact for Michael Carlet	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the REZI Form 4 filed for Michael Carlet report?

The Form 4 reports that Michael Carlet, Chief Financial Officer, acquired 1,540 shares of Resideo (REZI) on 08/09/2025 at a reported price of $27.37, bringing his beneficial ownership to 160,861 shares.

What transaction code is shown on the Form 4 for REZI insider activity?

The filing lists transaction code F for the reported common stock transaction.

Were any derivative securities reported in this REZI Form 4?

No. Table II for derivative securities contains no entries in the provided filing text.

Was the Form 4 filed by multiple reporting persons for REZI?

No. The form indicates it was filed by one reporting person.

Who signed the Form 4 for Michael Carlet?

The signature block shows the form was signed by Jeannine J. Lane, as Attorney-in-Fact for Michael Carlet with the signature date of 08/12/2025 in the filing text.